Report From CCC 2023: Switching to Infliximab Biosimilar Safe for Adolescents, Young Adults With IBD

Adolescents and young adults with inflammatory bowel disease can switch from the originator to a biosimilar of ...

JANUARY 20, 2023

Report From CCC 2023: Real-Time Dashboard Improves IBD Care With Automation

Data could be the key to improving population health in inflammatory bowel disease, and Phoenix Children’s ...

JANUARY 20, 2023

Exercise Often Missing Piece of IBD Treatment for Peds

Clinicians should consider prescribing exercise and physical activity to children with inflammatory bowel disease ...

OCTOBER 19, 2020

QI Pathway Improves Anemia Management in Pediatric IBD

Quality improvement protocols may greatly improve rates of screening for and management of iron deficiency and ...

APRIL 1, 2019

Gene Study Reveals Features of Pediatric IBD

Toronto—Whole exome sequencing of the largest pediatric cohort studied to date has confirmed the highly ...

JUNE 20, 2018

Bone Scans Underused In Peds With IBD

Children with inflammatory bowel disease (IBD) are at risk for impaired skeletal development, and many are ...

SEPTEMBER 14, 2016

Immune-Blocking Approach Safe for IBD in Peds

Immunosuppressive therapy is generally safe for pediatric-onset inflammatory bowel disease (IBD), according to ...

JUNE 25, 2016